Found: 2
Select item for more details and to access through your institution.
Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine.
- Published in:
- Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10071162
- By:
- Publication type:
- Article
Cardiogenic Shock during First Infusion of Anthracycline Chemotherapy in a Patient with Hodgkin Lymphoma: An Unusual Event.
- Published in:
- Cardiology, 2018, v. 139, n. 1, p. 7, doi. 10.1159/000480291
- By:
- Publication type:
- Article